CW Advisors LLC Purchases New Stake in Inspire Medical Systems, Inc. $INSP

Key Points

• CW Advisors LLC has acquired a new stake in Inspire Medical Systems, purchasing 34,384 shares worth approximately $5.48 million, which accounts for 0.12% of the company's stock.
• Inspire Medical Systems recently reported earnings, with $0.45 EPS, surpassing estimates and marking a 10.8% year-over-year revenue increase to $217.09 million.
• The company has authorized a $200 million share buyback program, indicating board confidence in the stock's value, and currently holds a consensus rating of "Moderate Buy" with an average price target of $165.62.

CW Advisors LLC bought a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 34,384 shares of the company's stock, valued at approximately $5,478,000. CW Advisors LLC owned approximately 0.12% of Inspire Medical Systems at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. SG Americas Securities LLC increased its holdings in shares of Inspire Medical Systems by 14.7% during the first quarter. SG Americas Securities LLC now owns 4,055 shares of the company's stock worth $646,000 after buying an additional 521 shares in the last quarter. GAMMA Investing LLC raised its position in Inspire Medical Systems by 253.7% in the first quarter. GAMMA Investing LLC now owns 573 shares of the company's stock valued at $91,000 after purchasing an additional 411 shares during the last quarter. New York State Teachers Retirement System raised its position in Inspire Medical Systems by 132.7% in the first quarter. New York State Teachers Retirement System now owns 21,390 shares of the company's stock valued at $3,407,000 after purchasing an additional 12,196 shares during the last quarter. Bessemer Group Inc. raised its position in Inspire Medical Systems by 1.7% in the first quarter. Bessemer Group Inc. now owns 7,183 shares of the company's stock valued at $1,145,000 after purchasing an additional 123 shares during the last quarter. Finally, Parallel Advisors LLC raised its position in Inspire Medical Systems by 356.5% in the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock valued at $33,000 after purchasing an additional 164 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on INSP shares. Robert W. Baird increased their target price on Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a research report on Tuesday, May 6th. Wells Fargo & Company dropped their target price on Inspire Medical Systems from $174.00 to $101.00 and set an "equal weight" rating for the company in a research report on Tuesday, August 5th. Lake Street Capital set a $150.00 target price on Inspire Medical Systems and gave the company a "buy" rating in a research report on Tuesday, August 5th. Piper Sandler dropped their target price on Inspire Medical Systems from $233.00 to $150.00 and set an "overweight" rating for the company in a research report on Tuesday, August 5th. Finally, JPMorgan Chase & Co. downgraded Inspire Medical Systems from an "overweight" rating to a "neutral" rating and lowered their price objective for the stock from $195.00 to $110.00 in a research report on Tuesday, August 5th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $165.62.

Inspire Medical Systems Stock Up 0.8%

Inspire Medical Systems stock traded up $0.75 during mid-day trading on Wednesday, hitting $92.50. 1,242,050 shares of the stock were exchanged, compared to its average volume of 686,141. Inspire Medical Systems, Inc. has a 12 month low of $73.92 and a 12 month high of $225.00. The firm's fifty day simple moving average is $116.12 and its two-hundred day simple moving average is $143.23. The stock has a market capitalization of $2.74 billion, a price-to-earnings ratio of 53.47, a PEG ratio of 2.90 and a beta of 1.22.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.23. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The firm had revenue of $217.09 million during the quarter, compared to analyst estimates of $214.50 million. During the same quarter last year, the business earned $0.32 EPS. The company's revenue was up 10.8% compared to the same quarter last year. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. As a group, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems announced that its board has authorized a stock repurchase plan on Monday, August 11th that authorizes the company to repurchase $200.00 million in shares. This repurchase authorization authorizes the company to buy up to 8.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's leadership believes its stock is undervalued.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.